Regular caffeine consumption by adolescents aged 13–18 poses significant risks to sleep, cardiovascular health, and neurocognitive development, and should be subject to stricter regulatory limits and public health guidance.

The argument synthesizes multiple independent lines of evidence — sleep physiology, neuroimaging, cardiovascular epidemiology, and longitudinal behavioral studies — to establish that caffeine's risks to the 13–18 age group are not merely theoretical but documented across body systems. The regulatory gap (no established safe limit, no sales restrictions) turns these health findings into a policy-relevant argument: the status quo exposes a vulnerable population to a stimulant whose harms are increasingly well-characterized, while the marketing environment actively encourages consumption.

• Caffeine disrupts adolescent sleep architecture: randomized crossover trials show it suppresses melatonin secretion and delays circadian timing, worsening the 'perfect storm' of developmental sleep pressure and early school schedules that already leaves over 70% of U.S. high schoolers sleeping less than the recommended 8 hours.
• Despite these converging risks, evidence-based safe consumption limits for adolescents do not yet exist, and caffeine-containing energy drinks continue to be aggressively marketed to teenagers with no uniform global age-restriction on sales.
• The adolescent brain is still undergoing critical development, including prefrontal cortex maturation, and data from the ABCD Study show that caffeine intake in youth is negatively associated with cognitive flexibility, processing speed, and functional brain network organization (default-mode / dorsal-attention anticorrelation).
• High caffeine intake in adolescents contributes to cardiovascular irregularities — elevated heart rate, blood pressure spikes, and arrhythmia risk — with caffeine-related emergency department visits among middle- and high-school students doubling over the past six years.
• Longitudinal evidence links adolescent caffeine use to increased daytime sleepiness, conduct problems, higher risk of substance dependence, and lower academic performance, suggesting cumulative rather than merely acute harms.

These are challenges this argument’s reasoning pattern must still withstand. Answering them on Isonomia strengthens the argument.

• Are the stated bad consequences likely to occur?Open
• Can the bad effects be mitigated so they are acceptable?Open
• Are there benefits that outweigh the bad effects?Open

No one has cited this argument yet.

No arguments cite this one yet — no one has built on or contested it. That is an absence of engagement, not a finding of soundness. Build on or contest it on Isonomia to change that.